These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16636663)
1. Regulation of STAT3-mediated signaling by LMW-DSP2. Sekine Y; Tsuji S; Ikeda O; Sato N; Aoki N; Aoyama K; Sugiyama K; Matsuda T Oncogene; 2006 Sep; 25(42):5801-6. PubMed ID: 16636663 [TBL] [Abstract][Full Text] [Related]
2. Physical and functional interactions between Daxx and STAT3. Muromoto R; Nakao K; Watanabe T; Sato N; Sekine Y; Sugiyama K; Oritani K; Shimoda K; Matsuda T Oncogene; 2006 Mar; 25(14):2131-6. PubMed ID: 16331268 [TBL] [Abstract][Full Text] [Related]
3. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity. Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969 [TBL] [Abstract][Full Text] [Related]
4. Physical and functional interactions between STAT3 and KAP1. Tsuruma R; Ohbayashi N; Kamitani S; Ikeda O; Sato N; Muromoto R; Sekine Y; Oritani K; Matsuda T Oncogene; 2008 May; 27(21):3054-9. PubMed ID: 18037959 [TBL] [Abstract][Full Text] [Related]
5. Physical and functional interactions between STAT3 and ZIP kinase. Sato N; Kawai T; Sugiyama K; Muromoto R; Imoto S; Sekine Y; Ishida M; Akira S; Matsuda T Int Immunol; 2005 Dec; 17(12):1543-52. PubMed ID: 16219639 [TBL] [Abstract][Full Text] [Related]
6. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Selvendiran K; Koga H; Ueno T; Yoshida T; Maeyama M; Torimura T; Yano H; Kojiro M; Sata M Cancer Res; 2006 May; 66(9):4826-34. PubMed ID: 16651438 [TBL] [Abstract][Full Text] [Related]
7. An RNA biding protein, Y14 interacts with and modulates STAT3 activation. Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751 [TBL] [Abstract][Full Text] [Related]
8. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Sekikawa A; Fukui H; Fujii S; Ichikawa K; Tomita S; Imura J; Chiba T; Fujimori T Carcinogenesis; 2008 Jan; 29(1):76-83. PubMed ID: 18024479 [TBL] [Abstract][Full Text] [Related]
9. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth. Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545 [TBL] [Abstract][Full Text] [Related]
10. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation. Sobota RM; Müller PJ; Heinrich PC; Schaper F Biochem J; 2008 May; 412(1):65-72. PubMed ID: 18271757 [TBL] [Abstract][Full Text] [Related]
12. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Samavati L; Rastogi R; Du W; Hüttemann M; Fite A; Franchi L Mol Immunol; 2009 May; 46(8-9):1867-77. PubMed ID: 19299019 [TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Fitzgerald JS; Tsareva SA; Poehlmann TG; Berod L; Meissner A; Corvinus FM; Wiederanders B; Pfitzner E; Markert UR; Friedrich K Int J Biochem Cell Biol; 2005 Nov; 37(11):2284-96. PubMed ID: 16125646 [TBL] [Abstract][Full Text] [Related]
14. Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes. Dráber P; Dráberová L; Heneberg P; Smíd F; Farghali H; Dráber P Cell Signal; 2007 Nov; 19(11):2400-12. PubMed ID: 17716862 [TBL] [Abstract][Full Text] [Related]
15. Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. Trevino JG; Gray MJ; Nawrocki ST; Summy JM; Lesslie DP; Evans DB; Sawyer TK; Shakespeare WC; Watowich SS; Chiao PJ; McConkey DJ; Gallick GE Angiogenesis; 2006; 9(2):101-10. PubMed ID: 16871430 [TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221 [TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Landen CN; Lin YG; Armaiz Pena GN; Das PD; Arevalo JM; Kamat AA; Han LY; Jennings NB; Spannuth WA; Thaker PH; Lutgendorf SK; Savary CA; Sanguino AM; Lopez-Berestein G; Cole SW; Sood AK Cancer Res; 2007 Nov; 67(21):10389-96. PubMed ID: 17974982 [TBL] [Abstract][Full Text] [Related]
19. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108 [TBL] [Abstract][Full Text] [Related]